Literature DB >> 19792996

Hyperkalemia-induced paralysis.

Nikita S Wilson1, Joanna Q Hudson, Zachary Cox, Tabitha King, Christopher K Finch.   

Abstract

Hyperkalemia is an electrolyte abnormality that can lead to severe consequences. Paralysis induced by hyperkalemia has been described in only a few reports. We describe a 60-year-old man who experienced paralysis presumably due to hyperkalemia. He presented to the emergency department with severe weakness in all extremities. The patient's serum potassium concentration was greater than 8 mEq/L and his serum creatinine concentration was 7 mg/dl. Findings on electrocardiography were abnormal. Of note, his drug therapy included lisinopril and naproxen. After treatment for hyperkalemia, the patient's symptoms resolved; however, he was admitted for further workup for renal failure. The patient was discharged after approximately 1 week with a diagnosis of end-stage renal disease. Use of the Naranjo adverse drug reaction probability scale indicated a probable relationship (score of 5) between the patient's paralysis and hyperkalemia. Although hyperkalemia as a cause of paralysis is extremely rare, clinicians should be aware of this potentially life-threatening, noncardiac toxicity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19792996     DOI: 10.1592/phco.29.10.1270

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  3 in total

1.  Renal Failure Patients in Disasters.

Authors:  Kenneth D Lempert; Jeffrey B Kopp
Journal:  Disaster Med Public Health Prep       Date:  2019-05-06       Impact factor: 1.385

2.  Acute ascending muscle weakness secondary to medication-induced hyperkalemia.

Authors:  Lauren A Kimmons; Justin B Usery
Journal:  Case Rep Med       Date:  2014-03-23

3.  Acute Ascending Flaccid Paralysis Secondary to Multiple Trigger Factor Induced Hyperkalemia.

Authors:  K H D Thilini Hemachandra; M B Kavinda Chandimal Dayasiri; Thamara Kannangara
Journal:  Case Rep Neurol Med       Date:  2018-05-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.